Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial

Year of publication

2018

Authors

Jerkeman, Mats; Eskelund, Christian Winther; Hutchings, Martin; Räty, Riikka; Wader, Karin Fahl; Laurell, Anna; Toldbod, Helle; Pedersen, Lone Bredo; Niemann, Carsten Utoft; Dahl, Christina; Kuitunen, Hanne; Geisler, Christian H.; Gronbaek, Kirsten; Kolstad, Arne

Organizations and authors

University of Helsinki

Räty Riikka

Oulu University Hospital

Kuitunen Hanne

Helsinki University Hospital

Räty Riikka

Publication type

Publication format

Article

Parent publication type

Journal

Article type

Original article

Audience

Scientific

Peer-reviewed

Peer-Reviewed

MINEDU's publication type classification code

A1 Journal article (refereed), original research

Publication channel information

Journal/Series

The Lancet Haematology

Parent publication name

The Lancet Haematology

Volume

Issue

Pages

E109-E116

ISSN

2352-3026

Publication forum

82975

Publication forum level

Open access

Open access in the publisher’s service

Yes

Open access of publication channel

Delayed open publication channel

Self-archived

Yes

Other information

Fields of science

Cancers

Keywords

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Publication country

Netherlands

Internationality of the publisher

International

Language

English

International co-publication

Yes

Co-publication with a company

DOI

10.1016/S2352-3026(18)30019-X

The publication is included in the Ministry of Education and Culture’s Publication data collection

Yes